Actively Recruiting
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
Led by Ictal Group · Updated on 2019-08-08
300
Participants Needed
1
Research Sites
564 weeks
Total Duration
On this page
Sponsors
I
Ictal Group
Lead Sponsor
V
Versailles Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Posterior Reversible Encephalopathy Syndrome prospective (PRES) registry. Data collection using a standardized form : demographic data and data related to the PRES, including circumstances of onset, dates and times of onset and of symptoms control, on-scene clinical findings, clinical and radiological features of PRES, pre-hospital and hospital care providers, timing of antiepileptic, antihypertensive drugs and supportive treatments, results of etiological investigations, cause of PRES, type and dosage of antiepileptic and antihypertensive drugs. Dates and times of EEG monitoring, EEG results, radiological and biological investigations. Outcomes including vital status and Glasgow Outcome Scale score at ICU and hospital discharge, day-90 and 1-year after SE and determined based on data in the ICU and/or neurologist charts and/or patients phone interview
CONDITIONS
Official Title
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of Posterior Reversible Encephalopathy Syndrome defined by a combination of consciousness impairment, seizure activity, headaches, visual abnormalities, nausea or vomiting, and focal neurological signs
- Cerebral imaging showing abnormalities in white matter (brain CT scan hypodensities and/or brain MRI hypoT1, hyper T2 FLAIR)
- Admission to an intensive care unit
You will not qualify if you...
- Normal cerebral imaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Intensive Care Unit - Versailles Hospital
Le Chesnay, France, 78150
Actively Recruiting
Research Team
S
Stephane LEGRIEL, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here